Related Experiment Video
Updated: Jul 16, 2026

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Hepatitis B virus seropositivity and the risk of stroke and myocardial infarction
Joohon Sung1, Yun-Mi Song, Yoon-Ho Choi
1Department of Preventive Medicine, Kangwon National University College of Medicine, Chunchon, Korea.
Insights
Hepatitis B virus surface antigen (HBsAg) seropositivity is linked to cardiovascular disease risk, but this association appears secondary to liver dysfunction, not HBsAg itself. Further research on hepatitis B and atherosclerosis is warranted.
Area of Science:
- Cardiology
- Hepatology
- Epidemiology
Background:
- Conflicting findings exist regarding the association between hepatitis B virus surface antigen (HBsAg) seropositivity and atherosclerosis.
- Hepatitis B viral infection is highly prevalent in Korea, necessitating investigation into its cardiovascular implications.
Purpose of the Study:
- To examine the association between HBsAg seropositivity and cardiovascular diseases (myocardial infarction and stroke) in a large Korean cohort.
- To determine if HBsAg seropositivity directly contributes to atherothrombosis or if the association is mediated by liver dysfunction.
Main Methods:
- A cohort of 521,421 Korean men aged 30-64 years was followed from 1990 to 2001.
- Participants were categorized by HBsAg seropositivity and liver dysfunction status.
- Cox proportional-hazards models were used to assess the risk of fatal and nonfatal myocardial infarctions and strokes.
Main Results:
- HBsAg seropositivity showed a decreased risk for ischemic stroke (HR 0.79) and myocardial infarction (HR 0.74), but an increased risk for hemorrhagic stroke (HR 1.33).
- In the absence of liver dysfunction, risks for stroke and MI were similar between HBsAg-seropositive and seronegative men.
- Men with both HBsAg seropositivity and liver dysfunction exhibited a higher risk of hemorrhagic stroke and lower risks of ischemic stroke and MI.
Conclusions:
- The observed associations between HBsAg seropositivity and stroke/MI are likely secondary to associated liver dysfunction.
- HBsAg seropositivity itself does not appear to be a significant factor in atherothrombosis via a proinflammatory effect.
Background And Purpose:
Conflicting findings on the possible association between hepatitis B virus surface antigen (HBsAg) seropositivity and atherosclerosis have been reported. We examined the association between HBsAg seropositivity and cardiovascular diseases in a cohort of Koreans with a high prevalence of hepatitis B viral infection.
Methods:
Men (N=521 421) aged 30 to 64 years were categorized into 4 groups according to HBsAg seropositivity status and the presence of liver dysfunction were followed up from 1990 to 2001 for both fatal and nonfatal myocardial infarctions (MIs) and strokes. The associations of HBsAg seropositivity with these cardiovascular diseases were examined with a Cox proportional-hazards model.
Result:
Overall, HBsAg seropositivity was associated with a decreased risk of ischemic stroke and MI and an increased risk of hemorrhagic stroke, with multivariable-adjusted hazard ratios (95% CIs) of 0.79 (0.68, 0.90), 0.74 (0.62, 0.87), and 1.33 (1.15, 1.52), respectively. Risks for stroke and MI were similar between HBsAg-seronegative and HBsAg-seropositive men in the absence of liver dysfunction, whereas men with both HBsAg seropositivity and liver dysfunction had a higher risk of hemorrhagic stroke and lower risks of ischemic stroke and MI compared with HBsAg-seronegative men.
Conclusions:
The association between HBsAg seropositivity and stroke and MI appears to be secondary to the liver dysfunction associated with hepatitis B viral infection. HBsAg seropositivity itself did not appear to play an important role in atherothrombosis through inducing a proinflammatory effect.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Arboviral Encephalitis
Ischemic Stroke ll: Pathophysiology